How much would you pay for a stock that might earn $25 a year in six years?
The biotech's shares dropped following its latest quarterly update, but that shouldn't matter to long-term investors.
These companies are raking in profits at astonishing clips.
New drugs in development and a lack of significant patent cliffs ahead make this a great pharma stock to buy now and hold over the long run.
VRTX earnings call for the period ending March 31, 2024.
June S&P 500 E-Mini futures (ESM24) are up +0.24%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.18% this morning as market participants looked ahead to a fresh batch of corporate earnings reports...
These great stocks are great picks for investors as spring winds down.
Monday U.S. Featured Earnings Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) (Q1) EPS of $3.66, ...
These healthcare stocks can provide enviable long-term portfolio growth.